Shkreli and Big Pharma’s Price Gouging are One and the Same
Former Turing Pharmaceuticals CEO Martin Shkreli is on Capitol Hill today, and he’ll be asked about his sky high drug price increase for Daraprim. But Turing’s drug price increase isn’t new or unique in the pharmaceutical industry. In just the past year, prices have been jacked up on hundreds of medications. The dirty secret is that Big Pharma’s price increases far exceed Daraprim’s. They contribute to BILLIONS in Medicare spending and are used by MILLIONS of Medicare beneficiaries. Below we will take a look at just 30 of those medications.